Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen

Technology appraisal guidance
Reference number: TA515
Published: 28 March 2018

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 232 KB)

Published:

28 March 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 353 KB)

Published:

22 February 2018
Committee papers (PDF 2.18 MB)

Published:

22 February 2018
Public committee slides (PDF 497 KB)

Published:

22 February 2018

Draft guidance

Draft guidance
Appraisal consultation document (PDF 358 KB)

Published:

27 November 2017
Committee papers (PDF 20.02 MB)

Published:

27 November 2017
Public committee slides Clinical Presentation Slides (PowerPoint 186 KB)

Published:

27 November 2017
Public committee slides Cost Presentation Slides (PowerPoint 635 KB)

Published:

27 November 2017

Invitation to participate

Final scope (PDF 240 KB)

Published:

11 October 2017
Final matrix (PDF 172 KB)

Published:

11 October 2017